{"status": "ok", "totalResults": 7, "articles": [{"source": {"id": null, "name": "SciTechDaily"}, "author": null, "title": "Russian Rocket Launches Astronaut, Cosmonaut, and Flight Attendant to ISS, Days After Glitch - SciTechDaily", "description": "NASA astronaut Tracy C. Dyson, Roscosmos cosmonaut Oleg Novitskiy, and Belarusian spaceflight participant Marina Vasilevskaya launched successfully to the ISS from Kazakhstan. Three crew members including NASA astronaut Tracy C. Dyson successfully launched at\u2026", "url": "https://scitechdaily.com/russian-rocket-launches-astronaut-cosmonaut-and-flight-attendant-to-iss-days-after-glitch/", "urlToImage": "https://scitechdaily.com/images/Soyuz-Rocket-Launches-Expedition-71-Crew-scaled.jpg", "publishedAt": "2024-03-24T09:45:02Z", "content": "The Soyuz rocket launches to the International Space Station with Expedition 71 NASA astronaut Tracy Dyson, Roscosmos cosmonaut Oleg Novitskiy, and Belarus spaceflight participant Marina Vasilevskaya\u2026 [+2063 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Online Bureau, ET HealthWorld", "title": "Spanish TB vaccine MTBVAC commences clinical trials in India - ETHealthWorld", "description": "The trials are carried out by Bharat Biotech in close collaboration with Biofabri. Trials to evaluate the safety and immunogenicity of MTBVAC have started with a pivotal safety, immunogenicity and efficacy trial planned to start in 2025.", "url": "https://health.economictimes.indiatimes.com/news/industry/spanish-tb-vaccine-mtbvac-commences-clinical-trials-in-india/108748686", "urlToImage": "https://etimg.etb2bimg.com/thumb/msid-108748686,imgsize-39750,width-1200,height=765,overlay-ethealth/industry/spanish-tb-vaccine-mtbvac-commences-clinical-trials-in-india.jpg", "publishedAt": "2024-03-24T09:36:58Z", "content": "Hyderabad: MTBVAC, the Spanish tuberculosis vaccine, the first live attenuated vaccine of Mycobacterium tuberculosis isolated from a human reaches a new milestone by starting clinical trials in India\u2026 [+4134 chars]"}, {"source": {"id": null, "name": "Hindustan Times"}, "author": "MD Ijaj Khan", "title": "ISRO's Nisar mission faces launch delay as key component returns to NASA for thermal precautions - HT Tech", "description": "NASA-ISRO Nisar mission faces launch delay as key component undergoes coating process to manage potential thermal issues in space.", "url": "https://tech.hindustantimes.com/tech/news/isros-nisar-mission-faces-launch-delay-as-key-component-returns-to-nasa-for-thermal-precautions-71711264421498.html", "urlToImage": "https://images.hindustantimes.com/tech/img/2024/03/24/1600x900/NISAR-spacecraft_1711264605653_1711264605818.png", "publishedAt": "2024-03-24T07:18:57Z", "content": "In a setback for the highly anticipated NISAR (NASA ISRO Synthetic Aperture Radar) mission, the joint endeavour between NASA and the Indian Space Research Organisation (ISRO) has hit a snag, pushing \u2026 [+2455 chars]"}, {"source": {"id": null, "name": "YouTube"}, "author": null, "title": "Galaxy A55 & Galaxy A35: AI in new Samsung phones | Tech It Out - WION", "description": "The mobile industry is becoming increasingly competitive. We caught up with Aditya Babbar, Vice President Of Mobile Experiences Business at Samsung India to ...", "url": "https://www.youtube.com/watch?v=6A1yepE6lN4", "urlToImage": "https://i.ytimg.com/vi/6A1yepE6lN4/maxresdefault.jpg", "publishedAt": "2024-03-24T04:30:02Z", "content": null}, {"source": {"id": null, "name": "Dailyexcelsior.com"}, "author": "Daily Excelsior", "title": "WHO guidance on drug-resistant TB 'need of hour', challenging to enforce, say experts - Daily Excelsior", "description": "NEW DELHI, Mar 23: The World Health Organization has issued a new guidance for diagnosing drug-resistant tuberculosis, describing it as a \u201cnovel approach\u201d that uses the \u201clatest technologies\u201d. While experts believe the approach has immense potential in bolster\u2026", "url": "https://www.dailyexcelsior.com/who-guidance-on-drug-resistant-tb-need-of-hour-challenging-to-enforce-say-experts/", "urlToImage": "https://cdndailyexcelsior.b-cdn.net/wp-content/uploads/2024/01/who.jpg", "publishedAt": "2024-03-24T00:00:31Z", "content": "NEW DELHI, Mar 23:The World Health Organization has issued a new guidance for diagnosing drug-resistant tuberculosis, describing it as a \u201cnovel approach\u201d that uses the \u201clatest technologies\u201d.While exp\u2026 [+4685 chars]"}, {"source": {"id": null, "name": "Wccftech"}, "author": "Alessio Palumbo", "title": "Baldur\u2019s Gate 3 Reportedly Sold 15 Million Copies; Vincke Hopes Next-Gen Tech Will Bring His Dream RPG Closer - Wccftech", "description": "It seems like Baldur's Gate 3 has already sold around 15 million copies. Larian CEO Swen Vincke also opened up on his dream RPG.", "url": "https://wccftech.com/baldurs-gate-3-reportedly-sold-15-million-copies-vincke-hopes-next-gen-tech-will-bring-his-dream-rpg-closer/", "urlToImage": "https://cdn.wccftech.com/wp-content/uploads/2023/07/bg3-art-2-HD-scaled.jpg", "publishedAt": "2024-03-23T20:12:00Z", "content": "Around a month ago, Larian's Michael Douse revealed that Baldur's Gate 3 had sold 'way over' 10 million units. In a new interview with Gamespot from GDC 2024, Larian CEO Swen Vincke provided an updat\u2026 [+3279 chars]"}, {"source": {"id": "financial-times", "name": "Financial Times"}, "author": "Hannah Murphy and Anna Mutoh, Financial Times", "title": "Reddit faces new reality after cashing in on its IPO - Ars Technica", "description": "Reddit must now answer to its shareholders as well as its vocal users.", "url": "https://www.ft.com/content/1a678f10-2fb4-4bfe-9552-4bcb5cedd3aa", "urlToImage": "https://cdn.arstechnica.net/wp-content/uploads/2024/03/spez-760x380.jpg", "publishedAt": "2024-03-23T10:10:48Z", "content": "Enlarge/ Steve Huffman, u/spez on Reddit, sold 500,000 of his shares in Reddits IPO on Thursday\r\n60\r\nIn an interview on the New York Stock Exchange trading floor ahead of Reddits market debut on Thur\u2026 [+5061 chars]"}]}